Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1093357

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1093357

North America Genotyping Market Size, Share & Industry Trends Analysis Report By Product (Reagents & Kits, Instruments, and Software & Services), By Application, By End Use, By Technology, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 96 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The North America Genotyping Market would witness market growth of 14.2% CAGR during the forecast period (2022-2028).

Genotyping with single-nucleotide polymorphism identifiers is currently frequently employed in small grain cereal genetic research and breeding. An almost limitless supply of SNP markers has been available due to various technologies such as the scanning of specific portions of the genome, such as transcribed sequences, or the resequencing of variety and lines.

Many samples are now routinely genotyped, especially within the context of genomic selection (GS), employing two distinct approaches such as genotyping-by-sequencing (GBS) and array-based genotyping with predetermined marker sets. Array-based genotyping in tiny grain breeding is evolving from pricey big arrays to smaller, freshly created second-generation arrays. Markers for specific phenotypes, along with high-quality polymorphic markers that are equally dispersed across the chromosomes and have little ascertainment bias, are included in such arrays.

Depending on a log-likelihood proportion calculation, genotype clusters are additionally categorized as non, a medium alert, or high alert. When compared to the concentration of the genotype across the country, alert levels reflect the degree of geographic intensity of cases in the same county or township area. American Indian or Alaska Native people and Native Hawaiian or Other Pacific Islander people continue to have the highest percentages of genotype-clustered cases.

The biggest number of clustered instances were seen among Hispanic or Latino people and non-Hispanic Black or African American people. The number of county-based clusters decreased by 5.3 percent from 1,351 in previous year's cases reported nationally from 2017 to 2019 to 1,280 in 2018-2020.

Universal TB genotyping entails sending at least one isolate to genotyping laboratories for every civilization TB patient in the country. The best understanding of the epidemiology of tuberculosis transmission inside a single TB program's jurisdiction, as well as across the country, would come from universal TB genotyping.

The US market dominated the North America Genotyping Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,381.6 million by 2028. The Canada market is estimated to grow at a CAGR of 16.8% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 15.8% during (2022 - 2028).

Based on Product, the market is segmented into Reagents & Kits, Instruments, and Software & Services. Based on Application, the market is segmented into Diagnostics & Personalized Medicine, Agricultural Biotechnology, Pharmacogenomics, Animal Genetics, and Others. Based on End Use, the market is segmented into Diagnostics & Research Laboratories, Pharmaceutical & Biopharmaceutical Companies, Academic Institutes, and Others. Based on Technology, the market is segmented into PCR, Sequencing, Capillary Electrophoresis, Microarray, Mass Spectrometry, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, and Fluidigm Corporation.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Reagents & Kits
  • Instruments
  • Software & Services

By Application

  • Reagents & Kits
  • Instruments
  • Software & Services

By End Use

  • Diagnostics & Research Laboratories
  • Pharmaceutical & Biopharmaceutical Companies
  • Academic Institutes
  • Others

By Technology

  • PCR
  • Sequencing
  • Capillary Electrophoresis
  • Microarray
  • Mass Spectrometry
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific Group
  • Fluidigm Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Genotyping Market, by Product
    • 1.4.2 North America Genotyping Market, by Application
    • 1.4.3 North America Genotyping Market, by End Use
    • 1.4.4 North America Genotyping Market, by Technology
    • 1.4.5 North America Genotyping Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Genotyping Market

Chapter 4. North America Genotyping Market by Product

  • 4.1 North America Reagents & Kits Market by Country
  • 4.2 North America Instruments Market by Country
  • 4.3 North America Software & Services Market by Country

Chapter 5. North America Genotyping Market by Application

  • 5.1 North America Diagnostics & Personalized Medicine Market by Country
  • 5.2 North America Agricultural Biotechnology Market by Country
  • 5.3 North America Pharmacogenomics Market by Country
  • 5.4 North America Animal Genetics Market by Country
  • 5.5 North America Others Market by Country

Chapter 6. North America Genotyping Market by End Use

  • 6.1 North America Diagnostics & Research Laboratories Market by Country
  • 6.2 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
  • 6.3 North America Academic Institutes Market by Country
  • 6.4 North America Others Market by Country

Chapter 7. North America Genotyping Market by Technology

  • 7.1 North America PCR Market by Country
  • 7.2 North America Sequencing Market by Country
  • 7.3 North America Capillary Electrophoresis Market by Country
  • 7.4 North America Microarray Market by Country
  • 7.5 North America Mass Spectrometry Market by Country
  • 7.6 North America Others Market by Country

Chapter 8. North America Genotyping Market by Country

  • 8.1 US Genotyping Market
    • 8.1.1 US Genotyping Market by Product
    • 8.1.2 US Genotyping Market by Application
    • 8.1.3 US Genotyping Market by End Use
    • 8.1.4 US Genotyping Market by Technology
  • 8.2 Canada Genotyping Market
    • 8.2.1 Canada Genotyping Market by Product
    • 8.2.2 Canada Genotyping Market by Application
    • 8.2.3 Canada Genotyping Market by End Use
    • 8.2.4 Canada Genotyping Market by Technology
  • 8.3 Mexico Genotyping Market
    • 8.3.1 Mexico Genotyping Market by Product
    • 8.3.2 Mexico Genotyping Market by Application
    • 8.3.3 Mexico Genotyping Market by End Use
    • 8.3.4 Mexico Genotyping Market by Technology
  • 8.4 Rest of North America Genotyping Market
    • 8.4.1 Rest of North America Genotyping Market by Product
    • 8.4.2 Rest of North America Genotyping Market by Application
    • 8.4.3 Rest of North America Genotyping Market by End Use
    • 8.4.4 Rest of North America Genotyping Market by Technology

Chapter 9. Company Profiles

  • 9.1 F. Hoffmann-La Roche Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.1 Recent strategies and developments:
      • 9.1.1.1 Partnerships, Collaborations, and Agreements:
  • 9.2 Danaher Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Acquisition and Mergers:
  • 9.3 Agilent Technologies, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
  • 9.4 Thermo Fisher Scientific, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Product Launches and Product Expansions:
  • 9.5 Qiagen N.V.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
  • 9.6 Illumina, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
      • 9.6.5.2 Product Launches and Product Expansions:
  • 9.7 Bio-Rad laboratories, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Product Launches and Product Expansions:
  • 9.8 Eurofins Scientific Group
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Recent strategies and developments:
      • 9.8.4.1 Acquisition and Mergers:
  • 9.9 Fluidigm Corporation
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 North America Genotyping Market, 2018 - 2021, USD Million
  • TABLE 2 North America Genotyping Market, 2022 - 2028, USD Million
  • TABLE 3 North America Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 4 North America Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 5 North America Reagents & Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 6 North America Reagents & Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 7 North America Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 8 North America Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 9 North America Software & Services Market by Country, 2018 - 2021, USD Million
  • TABLE 10 North America Software & Services Market by Country, 2022 - 2028, USD Million
  • TABLE 11 North America Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 12 North America Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 13 North America Diagnostics & Personalized Medicine Market by Country, 2018 - 2021, USD Million
  • TABLE 14 North America Diagnostics & Personalized Medicine Market by Country, 2022 - 2028, USD Million
  • TABLE 15 North America Agricultural Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 16 North America Agricultural Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 17 North America Pharmacogenomics Market by Country, 2018 - 2021, USD Million
  • TABLE 18 North America Pharmacogenomics Market by Country, 2022 - 2028, USD Million
  • TABLE 19 North America Animal Genetics Market by Country, 2018 - 2021, USD Million
  • TABLE 20 North America Animal Genetics Market by Country, 2022 - 2028, USD Million
  • TABLE 21 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 22 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 23 North America Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 24 North America Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 25 North America Diagnostics & Research Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 26 North America Diagnostics & Research Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 27 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 30 North America Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 31 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 34 North America Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 35 North America PCR Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America PCR Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Sequencing Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Sequencing Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Capillary Electrophoresis Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Capillary Electrophoresis Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Microarray Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Microarray Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Mass Spectrometry Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Mass Spectrometry Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Genotyping Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Genotyping Market by Country, 2022 - 2028, USD Million
  • TABLE 49 US Genotyping Market, 2018 - 2021, USD Million
  • TABLE 50 US Genotyping Market, 2022 - 2028, USD Million
  • TABLE 51 US Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 52 US Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 53 US Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 54 US Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 55 US Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 56 US Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 57 US Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 58 US Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 59 Canada Genotyping Market, 2018 - 2021, USD Million
  • TABLE 60 Canada Genotyping Market, 2022 - 2028, USD Million
  • TABLE 61 Canada Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 62 Canada Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 63 Canada Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 64 Canada Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 65 Canada Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 66 Canada Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 67 Canada Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 68 Canada Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 69 Mexico Genotyping Market, 2018 - 2021, USD Million
  • TABLE 70 Mexico Genotyping Market, 2022 - 2028, USD Million
  • TABLE 71 Mexico Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 72 Mexico Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 73 Mexico Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 74 Mexico Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 75 Mexico Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 76 Mexico Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 77 Mexico Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 78 Mexico Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 79 Rest of North America Genotyping Market, 2018 - 2021, USD Million
  • TABLE 80 Rest of North America Genotyping Market, 2022 - 2028, USD Million
  • TABLE 81 Rest of North America Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 82 Rest of North America Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 89 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 90 Key Information - Danaher Corporation
  • TABLE 91 key Information - Agilent Technologies, Inc.
  • TABLE 92 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 93 Key Information - Qiagen N.V.
  • TABLE 94 key information - Illumina, Inc.
  • TABLE 95 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 96 Key Information - Eurofins Scientific Group
  • TABLE 97 Key Information - Fluidigm Corporation

List of Figures

  • FIG 1 Methodology for the research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!